FDA grants priority review to Pfizer/BioNTech Covid-19 vaccine

Pfizer and BioNTech said Friday that the US Food and Drug Administration has granted priority review designation to their application for full approval of their Covid-19 vaccine, and an FDA official said the decision will come "soon".